Pavel Vodarek
Hradec Kralove, KR, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Comparable outcomes of BTK inhibitors and fixed-duration venetoclax plus rituximab in second-line treatment of chronic lymphocytic leukaemia: a real-world analysis by the Czech CLL study group.
Journal: Annals of hematology
Published: August 10, 2025
Are We Moving Toward Curative Approaches in Chronic Lymphocytic Leukemia?
Journal: Acta medica (Hradec Kralove)
Published: January 01, 2025
Complex evaluation of serum immunoglobulin levels in patients with chronic lymphocytic leukemia: Significant increase in IgA after first-line chemoimmunotherapy.
Journal: Cancer medicine
Published: June 11, 2023
Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR).
Journal: British journal of haematology
Published: December 29, 2022
A comprehensive assessment of lymphocyte subsets, their prognostic significance, and changes after first-line therapy administration in patients with chronic lymphocytic leukemia.
Journal: Cancer medicine
Published: July 27, 2022
COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group.
Journal: Annals of hematology
Published: April 11, 2022
Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia.
Journal: European journal of clinical investigation
Published: August 14, 2020
External validation of International Prognostic Score for asymptomatic early stage chronic lymphocytic leukaemia and proposal of an alternative score.
Journal: British journal of haematology
Published: July 16, 2020
Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: The GO-CLLEAR Study by the Czech CLL Study Group.
Journal: Hematological oncology
Published: February 01, 2020
Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies.
Journal: Journal of immunology research
Published: April 18, 2017
Rituximab infusion-related toxicity in patients with chronic lymphocytic leukemia
Journal: Vnitrni lekarstvi
Published: September 17, 2015
Last Updated: 09/26/2026